Kaleido Biosciences to Participate in the 41st Annual Canaccord Genuity Growth Conference

Rhea-AI Summary

Kaleido Biosciences (Nasdaq: KLDO) has announced that CFO William Duke will participate in a fireside chat at the Canaccord Genuity Growth Conference on August 12, 2021, at 2:30 PM ET. The presentation will be accessible via a webcast on the company's Investors & Media webpage. Kaleido focuses on a unique chemistry-driven approach to target the microbiome for disease treatment and health improvement, developing Microbiome Metabolic Therapies (MMTs) to address unmet patient needs. An archived replay will be available for 90 days post-event.

LEXINGTON, Mass., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that CFO William Duke will participate in a fireside chat at the Canaccord Genuity Growth Conference at 2:30PM ET on Thursday, August 12.

The webcast of the presentation will be made available in the Investors & Media section of Kaleido’s website at https://investors.kaleido.com/events-presentations. An archived replay will be available for 90 days following the event.

About Kaleido Biosciences
Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™). MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the gut’s existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs. To learn more, visit https://kaleido.com/.

Contacts:

Kaleido Biosciences
William Duke, Jr.
Chief Financial Officer
617-890-5772
william.duke@kaleido.com

Investors
Argot Partners
Kotaro Yoshida
212-600-1902
kaleido@argotpartners.com

FAQ

When is William Duke speaking at the Canaccord Genuity Growth Conference?

William Duke will speak at the Canaccord Genuity Growth Conference on August 12, 2021, at 2:30 PM ET.

Where can I watch the Kaleido Biosciences conference presentation?

The Kaleido Biosciences conference presentation can be watched via webcast on their Investors & Media webpage.

What is Kaleido Biosciences' focus regarding healthcare?

Kaleido Biosciences focuses on a chemistry-driven approach to target the microbiome for treating diseases and improving human health.

What are Microbiome Metabolic Therapies (MMT)?

Microbiome Metabolic Therapies (MMT) are designed to modulate the metabolic profile of the microbiome by enhancing gut microbe function.

How long will the webcast replay be available after the conference?

The archived replay of the webcast will be available for 90 days following the event.